Cerebral vasospasm after subarachnoid hemorrhage: the emerging revolution

@article{Macdonald2007CerebralVA,
  title={Cerebral vasospasm after subarachnoid hemorrhage: the emerging revolution},
  author={Robert L. Macdonald and Ryszard M. Pluta and John H. Zhang},
  journal={Nature Clinical Practice Neurology},
  year={2007},
  volume={3},
  pages={256-263}
}
Cerebral vasospasm is the classic cause of delayed neurological deterioration after aneurysmal subarachnoid hemorrhage, leading to cerebral ischemia and infarction, and thus to poor outcome and occasionally death. Advances in diagnosis and treatment—principally the use of nimodipine, intensive care management, hemodynamic manipulations and endovascular neuroradiology procedures—have improved the prospects for these patients, but outcomes remain disappointing. Recent clinical trials have… Expand
Novel treatments for cerebral vasospasm following aneurysmal subarachnoid hemorrhage.
TLDR
Preliminary experimental and clinical evidence indicate that targets in the inflammatory and oxidative cascades hold promise in reducing the incidence and impact of cerebral vasospasm. Expand
Neuroprotection in subarachnoid hemorrhage.
TLDR
The evolving understanding of the pathophysiology of delayed cerebral ischemia may offer the opportunity to test new therapeutic strategies in this area and improve clinical trial design. Expand
Vasospasm after aneurysmal subarachnoid hemorrhage: need for further study.
TLDR
Clazosentan reduced angiographic vasospasm in a dose-dependent manner in patients with aneurysmal SAH following coiling or clipping of the aneurYSm, and should have an important effect on clinical outcome. Expand
Cerebral vasospasm following subarachnoid hemorrhage: time for a new world of thought
TLDR
A key issue is the recognition of events other than arterial narrowing such as early brain injury and cortical spreading depression and of their contribution to overall mortality and morbidity. Expand
Pharmacological treatment of delayed cerebral ischemia and vasospasm in subarachnoid hemorrhage
TLDR
New pharmacological treatments are being developed to prevent and treat delayed cerebral ischemia after subarachnoid hemorrhage, with the only drug shown to be efficacious on both the incidence of vasospasm and poor outcome is nimodipine. Expand
New insights into the causes and therapy of cerebral vasospasm following subarachnoid hemorrhage.
TLDR
Therapies directed at many of the mechanisms behind cerebral vasospasm are currently under investigation and hold significant promise for an ultimate solution to this substantial problem. Expand
Endovascular options in the treatment of delayed ischemic neurological deficits due to cerebral vasospasm.
TLDR
The most common endovascular options-namely intraarterial vasodilators and transluminal balloon angioplasty-from the standpoint of mechanism, efficacy, limitations, and complications are discussed as well as the treatment algorithms for cerebral vasospasm used at this institution. Expand
Management of arterial vasospasm following aneurysmal subarachnoid hemorrhage.
TLDR
Management of patients following aSAH includes four major considerations: prediction of patients at highest risk for development of DCI, prophylactic measures to reduce its occurrence, monitoring to detect early signs of cerebral ischemia, and treatments to correct vasospasm and cerebral isChemia once it occurs. Expand
Pathophysiological Role of Global Cerebral Ischemia following Subarachnoid Hemorrhage: The Current Experimental Evidence
TLDR
The aim of the current paper is to review the pathophysiological events occurring in experimental models of SAH and global cerebral ischemia and to evaluate the contribution and the importance of global cerebral waschemia for the path physiology of SAh. Expand
Review of aneurysmal subarachnoid hemorrhage--focus on treatment, anesthesia, cerebral vasospasm prophylaxis, and therapy.
TLDR
Recent advances and future perspectives in the treatment of aSAH, early brain injury, and cerebral vasospasm are reviewed. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 65 REFERENCES
Cerebral Vasospasm after Subarachnoid Hemorrhage: Putative Role of Inflammation
TLDR
Investigations into the nature of the inflammatory response accompanying SAH are needed to elucidate the precise role(s) of inflammatory events in SAH-induced pathologies. Expand
Mechanisms of acute brain injury after subarachnoid hemorrhage
TLDR
A review of some of the mechanisms that contribute to acute cerebral injury after SAH will summarize some of these mechanisms. Expand
Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment.
  • R. Pluta
  • Medicine
  • Pharmacology & therapeutics
  • 2005
TLDR
A two-stage hypothesis of pathogenesis of delayed cerebral vasospasm is presented developed in the Vascular Laboratory of Surgical Neurology Branch of the National Institute of Neurological Disorders and Stroke using a primate model of SAH and suggests that the key treatment should be focused on preventing oxyHb neurotoxicity, inhibiting BOX production, and exogenous NO delivery. Expand
Thromboembolism and Delayed Cerebral Ischemia after Subarachnoid Hemorrhage: An Autopsy Study
TLDR
Thromboembolism after subarachnoid hemorrhage may contribute to delayed cerebral ischemia, which parallels that caused by vasospasm, and the pathogenesis of thromboEmbolism is discussed. Expand
Molecular mechanisms of early brain injury after subarachnoid hemorrhage
TLDR
Changing body of experimental and clinical data indicates that early brain injury after initial bleeding largely contributes to unfavorable outcome after subarachnoid hemorrhage (SAH), and detailed knowledge of molecular signaling pathways after SAH will serve to improve therapeutic interventions. Expand
Signaling mechanisms in cerebral vasospasm.
TLDR
The elusive nature of events that sustain cerebral vasospasm after subarachnoid hemorrhage resulting from a ruptured aneurysm presents major challenges in designing effective therapies for this frequently devastating condition, and the rationale for potential treatment modalities and their efficacy are discussed. Expand
No effect of enoxaparin on outcome of aneurysmal subarachnoid hemorrhage: a randomized, double-blind, placebo-controlled clinical trial.
TLDR
Routine use of low-molecular-weight heparin should be avoided during the early postoperative period in patients with SAH, because this agent seems to increase intracranial bleeding complications slightly, with no beneficial effect on neurological outcome. Expand
Does Vasospasm Occur in Small Pial Arteries and Arterioles of Rabbits?
TLDR
It is concluded that experimental chronic vasospasm after subarachnoid hemorrhage in rabbits tends to occur in large conducting arteries rather than in smaller pial arteries and arterioles. Expand
In vivo animal models of cerebral vasospasm: a review.
In vitro studies of subarachnoid hemorrhage (SAH) and vasospasm in animals involve the removal of the artery to be tested immediately after the animal has been killed [3]. The artery is then held inExpand
Neurovascular Protection Reduces Early Brain Injury After Subarachnoid Hemorrhage
TLDR
The major effect of z-VAD-FMK on early brain injury after SAH was probably neurovascular protection of cerebral endothelial cells, which results in less damage on BBB. Expand
...
1
2
3
4
5
...